ChartRow logo
Share this page
ICUI
$162.99-2.54%
as of close, Oct 16, 2026
☾ AH $162.99 -2.54%
PeersMRNALLYMDTUNHJNJTMO

ICUI financial statements

The full income statement, balance sheet, and cash-flow statement for ICU Medical Inc. (ICUI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 24.4M2024-09 24.5M2024-12 24.5M2025-03 24.6M2025-06 24.7M2025-09 24.7M2025-12 24.7M2026-03 25.0M2026-06 25.0M+2.4% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.23B-6.3%2.38B+5.4%2.26B-0.9%2.28B+73.2%1.32B+3.6%
822M-0.3%825M+11.5%740M+6.0%698M+42.0%491M+6.5%
Cost of revenue1.41B-9.5%1.56B+2.5%1.52B-4.0%1.58B+91.8%825M+1.9%
779M-0.3%782M+9.0%717M-3.2%741M+101.1%368M+1.4%
Research & development87.5M-1.3%88.6M+3.8%85.3M-8.2%93.0M+95.8%47.5M+10.6%
Selling, general & administrative625M-2.1%639M+5.3%607M-0.3%608M+101.1%303M+6.6%
Restructuring——5.70M-41.2%9.70M+638.9%-1.80M-122.8%
Amortization of intangibles131M-2.2%134M+1.7%132M-5.2%139M+485.7%23.8M+2.6%
Provision for credit losses—5.80M+592.1%838K-19.1%1.04M+200.3%345K-95.2%
Operating income42.8M-0.3%43.0M+88.2%22.8M+153.2%-42.9M-134.8%123M+25.6%
Interest expense93.3M-12.4%107M+3.7%103M+45.1%70.8M+8152.3%858K-51.1%
Net interest income-83.0M+13.3%-95.8M-0.6%-95.2M-43.5%-66.4M-3448.9%1.98M+3.0%
Other non-operating income-232K+98.2%-13.2M-123.9%-5.91M-15.0%-5.14M-151.6%-2.04M+21.3%
Equity-method income-1.19M0.000.00——
Pre-tax income4.36M+106.6%-66.0M+15.7%-78.3M——
Income tax2.44M-95.3%51.7M+206.2%-48.6M-21.2%-40.1M-300.1%20.1M+88.7%
Net income732K+100.6%-118M-296.9%-29.7M+60.1%-74.3M-172.0%103M+18.7%
$0.03+100.6%-$4.83-292.7%-$1.23+60.5%-$3.11-165.6%$4.74+17.9%
EPS (basic)$0.03+100.6%-$4.83-292.7%-$1.23+60.5%-$3.11-164.0%$4.86+16.8%
Weighted-avg shares (basic)24.6M+1.0%24.4M+1.2%24.1M+0.9%23.9M+12.6%21.2M+1.4%
Weighted-avg shares (diluted)24.9M+2.1%24.4M+1.2%24.1M+0.9%23.9M+9.6%21.8M+0.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.19B-17.4%1.44B+18.1%1.22B-1.1%1.24B+19.9%1.03B+11.8%
Cash & equivalents308M-0.2%309M+21.4%254M+21.8%209M-62.2%553M+39.6%
Cash & short-term investments—309M+21.1%255M+19.6%213M-62.4%567M+38.1%
Accounts receivable181M-1.3%183M+13.2%162M-27.1%222M+109.4%106M-14.7%
Inventory616M+5.3%585M-17.6%709M+1.9%696M+139.8%290M-7.8%
Prepaid expenses86.2M+5.7%81.5M+10.7%73.6M-17.2%88.9M+89.8%46.8M+12.9%
Other current assets25.5M+12.9%22.6M+516.1%3.67M+3.8%3.53M+58.6%2.23M+22.2%
4.05B-3.6%4.20B-4.0%4.38B-3.0%4.52B+140.1%1.88B+6.6%
Property, plant & equipment452M+2.0%443M-27.8%613M-3.6%636M+35.8%468M+0.4%
Operating lease right-of-use54.5M+2.2%53.3M-23.8%69.9M-6.6%74.9M+87.9%39.8M-14.4%
Goodwill1.50B+4.7%1.43B-2.7%1.47B+1.6%1.45B+3236.3%43.4M+31.6%
Intangible assets634M-14.5%741M-14.9%871M-11.4%983M+421.9%188M-4.5%
Deferred tax assets25.9M+6.9%24.2M-35.1%37.3M+18.5%31.5M-26.1%42.6M+37.3%
Other non-current assets62.9M-3.4%65.1M-30.8%94.0M-10.8%105M+65.4%63.7M+14.9%
499M-10.3%556M+15.4%482M-2.6%495M+146.3%201M+2.7%
Accounts payable154M+4.3%148M-1.3%150M-30.5%216M+166.1%81.1M+12.9%
Accrued liabilities315M+2.7%307M+14.4%268M+10.5%243M+105.4%118M+21.8%
Deferred revenue33.8M+11.5%30.4M-4.1%31.6M+2.6%30.8M+143.9%12.6M+127.2%
Short-term & current debt18.8M-63.2%51.0M+0.0%51.0M+71.8%29.7M0.00
Current lease liability13.8M-11.9%15.7M-22.2%20.2M+11.0%18.2M+101.7%9.01M+3.1%
Finance lease liability (current)2.10M+96.5%1.07M+24.0%860K+5.4%816K+26.9%643K+16.1%
Long-term debt1.27B-17.4%1.53B-2.9%1.58B-2.8%1.62B0.00
Deferred revenue (non-current)—9.04M-14.5%10.6M-34.8%16.2M0.00-100.0%
Non-current lease liability44.0M+7.8%40.8M-23.0%53.0M-13.0%60.9M+79.3%34.0M-17.2%
Operating lease liability (total)57.8M+2.3%56.5M-22.8%73.1M-7.5%79.1M+84.0%43.0M-13.6%
Finance lease liability (total)5.82M+71.4%3.40M+20.8%2.81M+5.4%2.67M-1.4%2.71M-7.9%
Finance lease liability3.73M+59.9%2.33M+19.3%1.95M+5.3%1.85M-10.3%2.07M-13.4%
Deferred tax liabilities37.8M-22.7%48.8M-12.6%55.9M-55.7%126M+8356.8%1.49M-10.4%
Other non-current liabilities89.5M+34.1%66.7M-33.6%100M-11.9%114M+172.8%41.8M-12.6%
2.12B+8.1%1.97B-7.4%2.12B+1.6%2.09B+29.3%1.62B+7.6%
Common stock2.47M+0.7%2.45M+1.6%2.41M+0.6%2.40M+12.7%2.13M+1.0%
Additional paid-in capital1.47B+3.8%1.41B+3.3%1.37B+2.6%1.33B+84.5%721M+4.1%
Retained earnings691M+0.1%690M-14.6%808M-3.5%838M-8.1%912M+12.8%
Treasury stock22.0K-76.1%92.0K-64.9%262K+7.8%243K+800.0%27.0K-30.8%
Accumulated other comprehensive income-34.6M+75.2%-139M-162.6%-53.1M+34.5%-81.0M-320.3%-19.3M-1166.0%
Total equity incl. non-controlling2.12B+8.1%1.97B-7.4%2.12B+1.6%2.09B+29.3%1.62B+7.6%
Total liabilities & equity4.05B-3.6%4.20B-4.0%4.38B-3.0%4.52B+140.1%1.88B+6.6%
Common shares issued24.7M+0.7%24.5M+1.5%24.1M+0.6%24.0M+12.8%21.3M+1.1%
Common shares outstanding24.7M+0.7%24.5M+1.6%24.1M+0.6%24.0M+12.7%21.3M+1.1%
Shares outstanding (cover)24.7M+0.7%24.5M+1.6%24.1M+0.6%24.0M+0.9%23.8M+12.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
180M-11.9%204M+22.8%166M+367.5%-62.1M-123.2%268M+20.1%
Depreciation & amortization201M-8.6%220M-4.0%229M-2.7%235M+162.2%89.7M+4.7%
Intangible amortization131M-2.2%134M+1.7%132M-5.2%139M+485.7%23.8M+2.6%
Share-based compensation55.8M+18.9%46.9M+15.6%40.6M+12.6%36.0M+31.8%27.3M+14.1%
Deferred income taxes-13.8M-343.1%5.67M+108.1%-69.9M-14.7%-61.0M-440.8%-11.3M-120.2%
Change in receivables-8.88M-118.9%46.8M+196.3%-48.6M-354.0%19.2M+239.2%-13.8M+82.4%
Change in inventory26.3M+256.0%-16.8M-376.8%6.08M-97.0%201M+1066.1%-20.8M-8.4%
Change in payables7.00M-44.2%12.5M+118.3%-68.3M-282.3%37.5M+1496.6%2.35M+105.1%
Other operating activities24.5M-25.0%32.6M-31.4%47.5M+22417.4%-213K-108.2%2.58M-62.8%
122M+237.4%-89.0M-1.2%-87.9M+95.4%-1.91B-2005.6%-90.7M+7.6%
Capital expenditure88.0M+10.9%79.4M-5.4%83.9M-7.1%90.3M+31.8%68.5M-25.5%
Free cash flow91.8M-26.4%125M+51.5%82.3M+154.0%-152M-176.6%199M+52.2%
Acquisitions0.000.000.00-100.0%1.84B+12660.6%14.5M
-312M-458.3%-55.8M-55.1%-36.0M-102.2%1.64B+9803.8%-16.9M-42075.0%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid303M+493.6%51.0M+71.8%29.7M+32.7%22.4M0.00
Common stock issued0.000.000.000.000.00
Common stock repurchased8.77M-26.9%12.0M+28.3%9.35M-14.1%10.9M+30.6%8.34M-35.3%
Dividends paid0.000.000.000.000.00
FX effect on cash8.85M+279.5%-4.93M-255.8%3.16M+133.4%-9.48M-191.5%-3.25M-213.9%
Net change in cash-603K-101.1%54.3M+19.6%45.4M+113.2%-344M-319.5%157M+23.0%
Interest paid83.7M-16.0%99.7M+4.0%95.9M+50.5%63.7M+7325.8%858K-51.1%
Income taxes paid28.9M+14.3%25.3M-29.5%35.8M+30.2%27.5M+40.6%19.6M-38.1%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap3.52B-7.4%3.80B+58.0%2.41B-36.2%3.78B-33.1%5.65B+24.5%
P/E4812.2×——91.4×+66.9%54.7×+4.9%
P/S1.6×-1.2%1.6×+49.2%1.1×-42.1%1.8×-56.9%4.3×+20.2%
P/B1.7×-14.3%1.9×+68.7%1.1×-36.2%1.8×-48.5%3.5×+15.8%
P/FCF38.4×+25.7%30.5×——28.4×-18.2%
Earnings yield0.02%——1.1%-40.1%1.8%-4.7%
FCF yield2.6%-20.5%3.3%——3.5%+22.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ICUI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ICUI filings on SEC EDGAR → Not investment advice.